Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Worel

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Vox Sanguinis|April 3, 2016
Relevance of flow cytometric enumeration of post-thaw leucocytes: influence of temperature during cell staining on viable cell recoveryG Fritsch, N Frank, J Dmytrus, et al.
Annals of Hematology|August 31, 2000
Low curative potential of bone marrow transplantation for highly aggressive acute myelogenous leukemia with inversioin inv (3)(q21q26) or homologous translocation t(3;3) (q21;q26)E Reiter, H Greinix, W Rabitsch, et al.
European Journal of Clinical Investigation|November 22, 2008
Comorbidity predicts survival in myelodysplastic syndromes or secondary acute myeloid leukaemia after allogeneic stem cell transplantationA Boehm, W R Sperr, G Leitner, et al.
Transfusion|May 29, 2000
Regeneration of erythropoiesis after related- and unrelated-donor BMT or peripheral blood HPC transplantation: a major ABO mismatch means problemsN Worel, H T Greinix, B Schneider, et al.
Annals of Hematology|August 25, 1999
Hematopoietic donor chimerism and graft-versus-myeloma effect in relapse of multiple myeloma after allogeneic bone marrow transplantationF Keil, P Kalhs, X Chen, et al.
Bone Marrow Transplantation|October 31, 2002
Long-term outcome and quality of life of patients who are alive and in complete remission more than two years after allogeneic and syngeneic stem cell transplantationN Worel, D Biener, P Kalhs, et al.
Leukemia|September 20, 2011
Significantly worse survival of patients with NIH-defined chronic graft-versus-host disease and thrombocytopenia or progressive onset type: results of a prospective studyZ Kuzmina, S Eder, A Böhm, et al.
Transfusion|February 13, 2001
PBPC mobilization with chemotherapy and G-CSF in patients with chronic myeloid leukemia: quantification of bcr/abl-positive cells by interphase fluorescence in situ hybridization and competitive PCRF Keil, G Mitterbauer, X Chen, et al.
Bone Marrow Transplantation|June 26, 2010
The addition of plerixafor is safe and allows adequate PBSC collection in multiple myeloma and lymphoma patients poor mobilizers after chemotherapy and G-CSFA D'Addio, A Curti, N Worel, et al.
Leukemia|March 10, 2001
Treatment of leukemic relapse after allogeneic stem cell transplantation with cytotoreductive chemotherapy and/or immunotherapy or second transplantsF Keil, E Prinz, P Kalhs, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Vox Sanguinis|April 3, 2016
Relevance of flow cytometric enumeration of post-thaw leucocytes: influence of temperature during cell staining on viable cell recoveryG Fritsch, N Frank, J Dmytrus, et al.
Annals of Hematology|August 31, 2000
Low curative potential of bone marrow transplantation for highly aggressive acute myelogenous leukemia with inversioin inv (3)(q21q26) or homologous translocation t(3;3) (q21;q26)E Reiter, H Greinix, W Rabitsch, et al.
European Journal of Clinical Investigation|November 22, 2008
Comorbidity predicts survival in myelodysplastic syndromes or secondary acute myeloid leukaemia after allogeneic stem cell transplantationA Boehm, W R Sperr, G Leitner, et al.
Transfusion|May 29, 2000
Regeneration of erythropoiesis after related- and unrelated-donor BMT or peripheral blood HPC transplantation: a major ABO mismatch means problemsN Worel, H T Greinix, B Schneider, et al.
Annals of Hematology|August 25, 1999
Hematopoietic donor chimerism and graft-versus-myeloma effect in relapse of multiple myeloma after allogeneic bone marrow transplantationF Keil, P Kalhs, X Chen, et al.
Bone Marrow Transplantation|October 31, 2002
Long-term outcome and quality of life of patients who are alive and in complete remission more than two years after allogeneic and syngeneic stem cell transplantationN Worel, D Biener, P Kalhs, et al.
Leukemia|September 20, 2011
Significantly worse survival of patients with NIH-defined chronic graft-versus-host disease and thrombocytopenia or progressive onset type: results of a prospective studyZ Kuzmina, S Eder, A Böhm, et al.
Transfusion|February 13, 2001
PBPC mobilization with chemotherapy and G-CSF in patients with chronic myeloid leukemia: quantification of bcr/abl-positive cells by interphase fluorescence in situ hybridization and competitive PCRF Keil, G Mitterbauer, X Chen, et al.
Bone Marrow Transplantation|June 26, 2010
The addition of plerixafor is safe and allows adequate PBSC collection in multiple myeloma and lymphoma patients poor mobilizers after chemotherapy and G-CSFA D'Addio, A Curti, N Worel, et al.
Leukemia|March 10, 2001
Treatment of leukemic relapse after allogeneic stem cell transplantation with cytotoreductive chemotherapy and/or immunotherapy or second transplantsF Keil, E Prinz, P Kalhs, et al.
Pageof 4